ArticleIrish journal of medical science2025
Low awareness of lipid disorders amongst individuals despite their high prevalence.
Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Service delivery interventions for lipid testing and lipid-lowering therapy for primary and secondary prevention of cardiovascular disease in adults.The Cochrane database of systematic reviews · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtherosclerotic cardiovascular disease (ASCVD) usually goes undetected until complications develop. Knowledge and awareness of cardiovascular risk factors, particularly lipid disorders, lead to earlier disease detection and risk factor intervention.
aimWe sought to assess the awareness of lipid disorders in a population randomly screened for lipid abnormalities.
methodsAs part of a national awareness campaign, 360 individuals underwent lipid screening and completed a questionnaire regarding their awareness of cardiovascular risk factors.
resultsWe identified 240 (66%) individuals with a lipid disorder. Lipid disorders were unrelated to gender but increased sharply from 39% in those under 40 years of age to (71%) in those between 40 and 54 years and (75%) in those older than 55 years. They were more prevalent in those reporting diabetes (78%), hypertension (88%) and hypercholesterolaemia (90%) but not in smokers 62% versus non-smokers 68%. Awareness of abnormal lipids was present in only 34% of individuals overall but was higher in those with diabetes (70%) hypertension (64%) or in those with two or more risk factors (50%). Awareness of lipid disorders increased with age, being extremely low (8%) in those under 40 years of age and increasing to (28%), (45%) and (54%) in those aged 40 to 54 years, 55 to 70 years and older than 70 years, respectively. The biggest gap between the presence and awareness of lipid disorders occurred in the 40 to 54 year age group. There were significant correlations between the awareness of lipid disorders and the awareness of hypertension r = 0.27, p < 0.01 or diabetes r = 0.14, p < 0.05 but not of smoking r = - 0.04 or family history of ASCVD r = 0.11.
conclusionsGiven the importance of early detection and intervention to reduce cardiovascular disease risk factors, public education and increased screening are advisable, especially for lipid disorders in the youngerage groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.